[Nervous system lesions in subjects with malignant neoplasms].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000556:secondary*; D001943:Breast Neoplasms / Q000150:complications; D002493:Central Nervous System Diseases / Q000139:chemically induced / Q000209:etiology*; D002648:Child; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000150:complications; D005833:Genital Neoplasms, Female / Q000150:complications; D006801:Humans; D007938:Leukemia / Q000150:complications; D008297:Male; D008875:Middle Aged; D010257:Paraneoplastic Syndromes; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D012878:Skin Neoplasms / Q000150:complications; D014571:Urologic Neoplasms / Q000150:complications
D000970:Antineoplastic Agents
Lesioni del sistema nervoso in soggetti con neoplasie maligne.